Loading...
TMS Co., Ltd.
4891.T•JPX
Healthcare
Biotechnology
¥160.00
¥-7.00(-4.19%)
TMS Co., Ltd. (4891.T) Financial Performance & Income Statement Overview
Analyze TMS Co., Ltd. (4891.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Revenue Growth
0.00%
Operating Income Growth
3.76%
↑ 3.76%
Net Income Growth
31.20%
↑ 31.20%
Operating Cash Flow Growth
39.99%
↑ 39.99%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-22.38%
↓ 22.38%
ROIC
-32.24%
↓ 32.24%
TMS Co., Ltd. (4891.T) Income Statement & Financial Overview
View the income breakdown for TMS Co., Ltd. 4891.T across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $145000.00 | $0.00 | $234000.00 | $3.24M |
| Gross Profit | -$145000.00 | $0.00 | -$234000.00 | -$3.24M |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $173.81M | $132.77M | $160.34M | $154.17M |
| SG&A Expenses | $77.51M | $71.23M | $68.65M | $65.84M |
| Operating Expenses | $251.32M | $204.09M | $228.99M | $220.009M |
| Total Costs & Expenses | $251.46M | $204.09M | $228.99M | $223.25M |
| Interest Income | $0.00 | $0.00 | $0.00 | $27000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $145000.00 | $1.74M | $1000.00 | $3.24M |
| EBITDA | -$319.77M | -$202.35M | -$228.99M | -$221.51M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$251.46M | -$204.09M | -$228.99M | -$223.25M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $273.80M | -$498000.00 | -$922000.00 | -$24.18M |
| Income Before Tax | $22.34M | -$204.59M | -$229.91M | -$247.43M |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $238000.00 | $237000.00 | $238000.00 | $237000.00 |
| Net Income | $22.10M | -$204.83M | -$230.15M | -$247.67M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | $0.55 | -$5.08 | -$5.71 | -$6.14 |
| Diluted EPS | $0.55 | -$5.08 | -$5.71 | -$6.14 |
| Weighted Avg Shares Outstanding | $40.20M | $40.33M | $40.31M | $40.30M |
| Weighted Avg Shares Outstanding (Diluted) | $40.20M | $40.33M | $40.31M | $40.30M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan